High CIB1 expression in colorectal cancer liver metastases correlates with worse survival and the replacement histopathological growth pattern.
CIB1
MT: Regular Issue
colorectal cancer
histopathological growth patterns of liver metastasis
patient-derived organoids
single-cell RNA sequencing
spatial transcriptomics
Journal
Molecular therapy. Oncology
ISSN: 2950-3299
Titre abrégé: Mol Ther Oncol
Pays: United States
ID NLM: 9918752083706676
Informations de publication
Date de publication:
19 Sep 2024
19 Sep 2024
Historique:
received:
02
02
2024
revised:
16
05
2024
accepted:
07
06
2024
medline:
29
7
2024
pubmed:
29
7
2024
entrez:
29
7
2024
Statut:
epublish
Résumé
To date, nearly one-quarter of colorectal cancer (CRC) patients develop liver metastases (CRCLM), and its aggressiveness can be correlated to defined histopathological growth patterns (HGP). From the three main HGPs within CRCLM, the replacement HGP emerges as particularly aggressive, characterized by heightened tumor cell motility and vessel co-option. Here, we investigated the correlation between the expression of calcium- and integrin-binding protein 1 (CIB1), a ubiquitously expressed gene involved in various cellular processes including migration and adhesion, and disease-free (DFS) and overall survival (OS) in primary CRC patients. Additionally, we explored the correlation between CIB1 expression and different HGPs of CRCLM. Proteomic analysis was used to evaluate CIB1 expression in a cohort of 697 primary CRC patients. Additionally, single-cell and spatial RNA-sequencing datasets, along with publicly available bulk sequencing data were used to evaluate CIB1 expression in CRCLM.
Identifiants
pubmed: 39072289
doi: 10.1016/j.omton.2024.200828
pii: S2950-3299(24)00070-5
pmc: PMC11278321
doi:
Types de publication
Journal Article
Langues
eng
Pagination
200828Informations de copyright
© 2024 Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.
Déclaration de conflit d'intérêts
The authors declare no competing interests.